Brief: Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
13/02/2025 22:24
Esperion Therapeutics Inc ESPR.O :
* ESPERION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING
RULE
5635(C)(4)
Source text: ID:nGNXFSDLW
Further company coverage: ESPR.O
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi